REGULATORY NEWS
 |
U.S. FDA RELEASE OF NEW SUNSCREEN LABELING REGULATIONS AND THE IMPACT ON YOUR PACKAGING
The long awaited Proposed Amendment of the Final Monograph for the
labeling of all sunscreen products in the USA has been released.
The ruling is in the Federal Register, Docket No. 1978N-0038, also available on-line HERE.
Our preliminary evaluation of this ruling indicates MANY significant changes to ALL your sunscreen packaging:
-
First and most important to all of us...The FDA has allowed no
significant alleviation of the standard Drug Facts Panel for sunscreen
make-ups, skin moisturizers and the like except as already outlined for
"products labeled for use only on specific small areas of the face
(e.g., lips, nose, ears, and/or around the eyes)" and meeting all other
criteria for small packages as stated in the original monograph.
- For the Drug Facts Panel itself there are changes and additions in the verbiage to the Uses, Warnings and Directions sections.
-
Additionally there are significant NEW items required for the PDP
(Principal Display Panel) for UVA designations and even changes to the
existing UVB SPF designations.
- The SPF values can go as high as 50+, which is changed from the original limit of 30+.
-
The date for implementation is 18 months based on the date of issuance
of the final rule. The final rule date will take into consideration the
time needed for the comment period of this proposed rule, all of which
is part of the process required by law for all FDA regulations.
Stay tuned to the H+Y Regulatory News Flash for
more details as this regulation progresses and the impact this ruling
will have on your packaging is determined in detail. |
| |
|
 |
| |
|
 |
U.S. FDA PROPOSES ALTERNATIVE LABELING REQUIREMENTS FOR CONVENIENCE-SIZE OTC PRODUCTS On December 12th, in response to a citizen petition, the FDA issued the long-awaited (it's been delayed since 2002) proposed rule on convenience-size OTCs. The proposed rule includes a definition of "convenience-size" products and amended Drug Facts Labeling content and format requirements. The words "See information inside before using," in at least 7-point bold italic type, will now have to be added to many of these labels. Look for H+Y's detailed summary of these labeling regulations in our next newsletter. |
 |
 |
 |
|
 |
 |
 |
 |
U.S. FDA REGULATORY AGENDA:
ISSUES OF INTEREST
As published in the Federal Register on December 11th, the following are tentative goals for future rulemaking related to cosmetic-drugs:
Sunscreens - proposed rule on Ultraviolet A and Ultraviolet B testing and labeling requirements: 12/06
Skin bleaching products - proposed rule on hydroquinone comment period ends: 12/27/06
Skin protectants - final rule on lip protectant, technical amendments: 3/07
Dandruff, seborrheic dermatitis, and psoriasis products -final rule on coal tar and menthol combinations: 6/07 |
| |
|
 |
| |
|
 |
EU SUNSCREEN LABELING On September 22, 2006 the EU Commission adopted a Recommendation on how sunscreens sold in the EU should be labeled. This recommendation lays out specifics regarding labeling claims, precautions, minimum efficacy standards and efficacy indicator words, such as low, medium and high protection. |
 |
 |
 |
 |
U.S. FDA SET TO BAN OTC SKIN-BLEACHING PRODUCTS Due to evidence that hydroquinone causes carcinogenicity in rodents and disfiguring in humans, FDA proposes that skin-bleaching drugs should be restricted to prescription use only. |
 |
 |
 |
 |
HEALTH CANADA PUBLISHES NEW NHP AND DRUG MONOGRAPHS TPD and NHPD have finalized four new personal care product monographs: Sunburn Protectants, Acne Therapy, Antidandruff Products, and Antiseptic Skin Cleansers |
 |
 |
 |
 |
U.S. FDA PROPOSES NDC NUMBER ON COSMETIC-DRUGS According to a Proposed Rule on Registration and Listing for Human Drugs, a National Drug Code (NDC) number may soon be required on all OTC drug packaging, including those also regulated as cosmetics (such as SPF, acne, anti-dandruff & antiperspirant products). |
|